Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-06-23 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-06-18 Financing
AVRICORE HEALTH CLOSES $1.254 MILLION FINANCING
News release - English.pdf
Results 2026-06-01
Interim MD&A - English.pdf
Results 2026-06-01
Interim financial statements/report – English.pdf
Transactions 2026-05-20 Financing
Avricore Health Announces $1.25 Million Financing
News release - English.pdf
Results 2026-05-01
Annual MD&A - English.pdf
Results 2026-05-01
Audited annual financial statements – English.pdf
News 2026-04-21
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab Platform
News release - English.pdf
Results 2025-12-02 Financials
Interim MD&A - English.pdf
Results 2025-12-02 Financials
Interim financial statements/report – English.pdf
News 2025-11-28
Avricore Health Inc. Announces HealthTab™ Pilot to Power NHS Initiative for Cholesterol-Lowering Injections in Community Pharmacies
News release - English.pdf
Results 2025-08-29 Financials
Interim MD&A - English.pdf
Results 2025-08-29 Financials
Interim financial statements/report – English.pdf